Published in
Elsevier, Gynecologic Oncology, 1(163), p. 93-99, 2021
DOI: 10.1016/j.ygyno.2021.07.033
Links
Tools
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu
Journal article published in 2021 by
Joan Tymon-Rosario,
Eric R. Siegel,
Stefania Bellone,
Justin Harold,
Naomi Adjei,
Burak Zeybek,
Dennis Mauricio,
Gary Altwerger,
Gulden Menderes,
Elena Ratner,
Mitchell Clark,
Vaagn Andikyan,
Gloria S. Huang 
,
Masoud Azodi,
Peter E. Schwartz
and other authors.
,
Masoud Azodi,
Peter E. Schwartz
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 